Open for Investment

Charter Hall Direct PFA Fund (PFA)

Resources

Here you will find useful documents relating to the fund including the Product Disclosure Statement and fund brochure, quarterly reports, financial reports, registry forms for managing your investment and documents for advisers.

Fund Documents

PFA

Product Disclosure Statement (PDS) and application form

PFA is open to applications using the PDS dated 29 August 2022. For investment of $20,000 and above. See the Liquidity section of the website for further information on the 2022 Liquidity Event and the Quarterly Updates for current Fund information.

PFA

RG46 & PDS Updated Information

In line with ASIC Regulatory Guide 46 (RG46) the Disclosure Guide provides information in the interests of improved disclosure for retail investors.

PFA

Target Market Determination (TMD)

The TMD sets out the class of consumers for whom the product, including its key attributes, would likely be consistent with their likely objectives, financial situation and needs.

Investor Documents

PFA

Investor Brochure

A general overview of the product offering for prospective investors.

Adviser Documents

PFA

Zenith Report

Fund rating and information for financial advisers only. PFA was rated Highly Recommended.*

PFA

Product Profile

A short overview of the product including platform availability, fund performance and property portfolio.

PFA

Lonsec Report

Fund rating and information for financial advisers only. PFA was rated Recommended.^

Quarterly Updates

Registry Forms

TFN and ABN

Surviving Holder

Standard Transfer

Change of Personal Details

Change of Bank Account Details

Appointment of Agent

Adviser Appointment

eForm - Deceased Estate Withdrawal Request (Wrap)

Deceased Estate Withdrawal Form

Important Information

The responsible entity of and issuer of units in the Charter Hall Direct PFA Fund (ARSN 097 860 690) (Fund) is Charter Hall Direct Property Management Limited (CHDPML) (ABN 56 073 623 784; AFSL 226849). CHDPML as responsible entity for the Fund has issued a Product Disclosure Statement (PDS) dated 29 August 2022 and any supplementary PDS, which set out the offer to apply for units in the Fund, and has made a target market determination (TMD) for the Fund. This website is not intended to be and does not constitute a Product Disclosure Statement or disclosure document as those terms are defined in the Corporations Act 2001 (Cth). It does not constitute an offer for the issue sale or purchase of any securities or any recommendation in relation to investing in any asset. This website has been prepared without taking account of any particular investor's objectives financial situation or needs. While every care has been taken in the preparation of this website, CHDPML does not make any representation or warranty as to the accuracy or completeness of any statement in it, including without limitation any forecasts or opinions, and persons viewing this website should conduct their own inquiries and investigations. Forecasts, opinions and estimates provided on this website are based on assumptions, contingencies and market conditions which are subject to change without notice, and may involve significant elements of subjective judgement and assumptions as to future events which may or may not be correct, and should not be relied upon as an indication of future performance. Past performance is not a reliable indicator of future performance. Distribution forecasts are subject to risks outlined in the PDS and distributions may vary in the future. The information contained on this website is subject to change, and CHDPML is not responsible for providing updated information to any person. To the maximum extent permitted by law CHDPML disclaims all liability for any loss or damage which may arise out of the provision to or are by any person of the information contained on this website. All figures stated herein are in Australian dollars unless otherwise stated. If you are considering an investment in any Fund (or making a decision about continuing to hold units in any Fund) you should read the PDS in its entirety and consider the information set out in the PDS in relation to the offer. The PDS sets out the benefits and features of the Fund and the risks of, and fees and costs associated with, investing in the Fund. You can request a copy of the PDS and the TMD, free of charge, by calling CHDPML on 1300 652 790 and they are also available on this website or by contacting your financial adviser. Applications for units in in any Fund can only be made under the application form enclosed with the relevant PDS. As this website has been prepared without taking account of any particular investor's objectives financial situation or needs, it is important that you consider the PDS for the offer and seek appropriate professional advice having regard to your objectives financial situation and needs before making any investment decision in relation to the offer or the Fund. CHDPML does not receive fees in respect of the general financial product advice it provides, however it will receive fees for operating the Fund, in accordance with the Fund’s constitution. Entities within the Charter Hall Group may also receive fees for managing the assets of, and providing resources to, the Fund which are generally based on the value of the Fund’s assets. For more detail on fees, see the PDS. Any investment is subject to risk, including possible delays in payment and loss of income and principal invested. You should read the PDS for a description of the risks associated with investing in the Fund. You should read the TMD for a description of the target market of the Fund. Neither CHDPML nor any of its associates, related entities or directors guarantee the performance of any investment or the repayment of monies invested. If this website states that any Fund has been rated or has received a rating, you should be aware that ratings are only one factor to be taken into account when deciding whether to invest in the Fund.

* The Zenith Investment Partners Pty Ltd (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (Charter Hall Direct Office Fund (APIR MAQ0842AU), Charter Hall Direct PFA Fund (APIR MAQ5880AU), Charter Hall Direct Industrial Fund No.4 (APIR MAQ0854AU), Charter Hall Direct Long WALE Fund (APIR MAQ5703AU), Charter Hall Wholesale Property Series No.2 (APIR MAQ5760AU) (all assigned 13 December 2023) and Charter Hall Maxim Property Securities Fund (APIR COL0001AU) (assigned 10 July 2023) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at https://www.zenithpartners.com.au/our-solutions/investment-research/regulatory-guidelines/

^ The Lonsec ratings issued for the Charter Hall Direct Office Fund (assigned November 2023), Charter Hall Direct PFA Fund (assigned November 2023), Charter Hall Direct Industrial Fund No.4 (assigned November 2023), Charter Hall Direct Long WALE Fund (assigned November 2023) and the Charter Hall Maxim Property Securities Fund (assigned May 2023) are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2024 Lonsec. All rights reserved.